Healthcare Resource Utilization and Direct Cost of Patients with Atopic Dermatitis in Dubai, United Arab Emirates: A Retrospective Cohort Study.

Anwar Al HammadiJaheersha PakranMohamed FarghalyHaytham Mohamed AhmedAmy ChaDilara BalkanSherif AfifiBadarinath Chickballapur RamachandracharAshok NatarajanSreenivasulu LingaKhadija Al Jefri

Published in: Dermatology and therapy (2022)

This study indicated AD to be a common skin disease with a prevalence rate of 4-5% in Dubai (UAE), with the majority of patients (about 90%) being treated by specialists. However, there is a significant underuse of newer innovative therapies (including biologics). Also, disease severity (moderate-to-severe AD) was associated with high direct medical cost, which could be controlled by early intervention. Furthermore, AD treatment choice could focus on major direct HCRU cost contributors such as hospitalizations, comorbid conditions, and infections.

Keyphrases

healthcare
end stage renal disease
newly diagnosed
atopic dermatitis
randomized controlled trial
chronic kidney disease
risk factors
prognostic factors
social media
drug induced
patient reported